Standard Operating Procedure for Control of Analytical Reports Used in Regulatory Filings
| Department | Regulatory Affairs |
| SOP No. | RA/2026/721 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 14/04/2026 |
| Effective Date | 14/04/2026 |
| Review Date | 14/04/2028 |
Purpose
This Standard Operating Procedure (SOP) defines the systematic process for the control, handling, review, and archival of analytical reports used in regulatory filings. The objective is to ensure that all analytical data submitted to regulatory authorities is accurate, complete, consistent, and compliant with applicable regulatory requirements and internal quality systems, thereby supporting timely and reliable regulatory submissions.
Scope
This SOP applies to all analytical reports generated by quality control, quality assurance, research laboratories, and external contract laboratories, which are intended for inclusion in regulatory dossiers across all dosage forms, manufacturing processes, and product types managed by the organization. It encompasses activities from receipt or generation of reports through review, approval, documentation, filing, and retention. Exclusions include internal analytical data not submitted to regulatory bodies and reports related solely to routine manufacturing batch release not intended for regulatory filing.
Responsibilities
- Analytical Laboratory Personnel: Generate analytical reports in accordance with approved methods and templates.
- Quality Assurance (QA): Review and verify the analytical reports for compliance, completeness, and accuracy prior to regulatory submission.
- Regulatory Affairs (RA): Coordinate receipt and filing of analytical reports within regulatory submission dossiers and ensure control per SOP.
- Document Control/Records Management: Manage secure storage, access controls, and archiving of analytical reports.
- Supervisors and Managers: Oversee adherence to SOP, approve deviations, and ensure appropriate training.
Accountability
The Head of Regulatory Affairs holds overall accountability for the implementation, compliance monitoring, periodical review, and effectiveness evaluation of this SOP. Escalation of issues or non-compliance related to analytical report control resides with this role.
Procedure
1. Preparation and Prerequisites: Ensure all analytical methods are validated and all analytical reports follow the approved templates and formats. Confirm access to controlled document management systems and secure storage facilities for physical and electronic reports.
2. Receipt or Generation of Reports: Upon completion of analysis, the laboratory generates the analytical report, including raw data summaries, test results, deviations, and remarks as per the approved format. Reports must be checked for completeness by the responsible analyst prior to submission.
3. Initial Verification: QA reviews the analytical report for accuracy, validity of results, and compliance with method acceptance criteria. Any discrepancies, deviations, or out-of-specification (OOS) results must be documented and investigated as per applicable SOPs.
4. Approval and Documentation: After successful review, the QA approves the report by signature and date. The report is then forwarded to Regulatory Affairs for inclusion in the relevant dossier or regulatory submission package.
5. Filing and Record Retention: Regulatory Affairs ensures that the approved analytical reports are filed in designated approved controlled storage systems (electronic or physical) with restricted access to prevent unauthorized changes. Records are retained as per regulatory and organizational data retention policies.
6. Change Control and Updates: Any amendments or corrections to analytical reports require proper documentation with version control and rationale. Revised reports must undergo the same review and approval process.
7. Deviation and Exception Handling: Any deviation from this SOP, including missing or incomplete reports, must be reported immediately to QA and RA management and handled in accordance with deviation management procedures.
8. Training: All personnel who generate, review, or handle analytical reports for regulatory filings must be trained on this SOP and related compliance requirements.
9. Periodic Review and Audit: The effectiveness of report control is reviewed at least annually during internal audits or management reviews. Findings are addressed via corrective/preventive action.
10. Closure: Once the regulatory submission is complete and reports are archived, periodic reviews ensure records remain intact, legible, and retrievable for the required retention period.
Abbreviations
- QA – Quality Assurance
- RA – Regulatory Affairs
- OOS – Out Of Specification
- SOP – Standard Operating Procedure
- CFR – Code of Federal Regulations
- GMP – Good Manufacturing Practice
Documents
- Analytical Report Template (Annexure-1)
- Analytical Report Review Checklist (Annexure-2)
- Analytical Report Filing Log (Annexure-3)
References
- 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
- ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
- ICH Q10 – Pharmaceutical Quality System
- EU GMP Annex 11 – Computerized Systems
- Internal Quality Management System Documentation
- Company Document and Records Retention Policy
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Analytical Report Template
Purpose: To provide a standardized format for all analytical reports used in regulatory filings ensuring consistency, completeness, and compliance with regulatory requirements.
| Report No. | AR-2026-1357 |
| Sample ID | PRD-2026-045 |
| Date of Analysis | 10/04/2026 |
| Analyst Initials | AA |
| Method Reference | HPLC-1234 Rev 5 |
| Dosage Form | Tablet |
| Test Parameters | Assay, Related Substances, Dissolution |
| Results | Assay: 99.5% | Related Substances: <0.5% | Dissolution: 85% at 30 min |
| Acceptance Criteria | Assay 98.0-102.0%, Related Substances ≤1.0%, Dissolution ≥80% |
| Deviations Noted | None |
| Reviewed By | QA Reviewer |
| Approval Date | 12/04/2026 |
Annexure-2: Analytical Report Review Checklist
Purpose: To ensure that all aspects of the analytical report are reviewed comprehensively prior to regulatory filing.
| Checklist No. | CHK-AR-789 |
| Date of Review | 13/04/2026 |
| Report Number | AR-2026-1357 |
| Reviewer Initials | QR |
| Criteria | Verification Status |
| • Completeness of Data | Yes |
| • Consistency with Method | Yes |
| • Correct Calculations | Yes |
| • Deviation Documentation | Not Applicable |
| • Approval Signature Present | Yes |
| Comments | No discrepancies found. |
Annexure-3: Analytical Report Filing Log
Purpose: To track the filing and retrieval of analytical reports submitted for regulatory purposes, ensuring traceability and controlled access.
| Report No. | Date Filed | Filed By | Storage Location | Access Restrictions | Remarks |
|---|---|---|---|---|---|
| AR-2026-1357 | 14/04/2026 | Regulatory Affairs | Secure Electronic Repository – Folder RA/2026 | Read-Only Access for QA and RA only | Filed for Regulatory Submission Q2 2026 |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 14/04/2026 | 1.0 | Initial issue | New SOP creation |